...
首页> 外文期刊>BJU international >Modified ureterosigmoidostomy (Mainz Pouch II) in different age groups and with different techniques of ureteric implantation.
【24h】

Modified ureterosigmoidostomy (Mainz Pouch II) in different age groups and with different techniques of ureteric implantation.

机译:改良的输尿管乙状结肠造口术(Mainz Pouch II)在不同的年龄段和采用不同的输尿管植入技术。

获取原文
获取原文并翻译 | 示例
           

摘要

In this section there are papers on three types of urinary diversion which are in common use. Authors from Germany, Greece and Turkey describe their experience with the Mainz pouch II, S-pouch neobladder and modified Hautmann bladder, respectively. OBJECTIVE To examine the outcome of Mainz Pouch II urinary diversion in different age groups and with different techniques of ureteric implantation. PATIENTS AND METHODS Between March 1995 and August 2002 a Mainz Pouch II was created in 41 patients (27 male and 14 female, median age 56.3 years, range 2-75) with 81 renal units (RU). For analysis, the patients were divided into 29 (70%) aged <65 years and 12 (30%) aged >65 years. Ureteric implantation with the Goodwin-Hohenfellner (GH) technique was used in 55 RU, with the Abol-Enein (AE) modification in 23 and Le-Duc procedure in three. The median (range) follow-up (available for 36 patients, 88%) was 19 (1-80) months. An unvalidated questionnaire was used to determine specific urinary diversion items. RESULTS Early complications occurred in 7% of patients, none requiring surgical intervention. Pyelonephritis occurred in five of 36 patients and seven of 71 RU (14% of the patients, 10% of the RU); all patients were <65 years old. In five of seven RU pyelonephritis was caused by the development of upper urinary tract dilatation; none required surgical revision. Ureteric stenosis requiring reimplantation occurred in two RU (2%, one GH, one AE). All patients were continent in the daytime; all but one patient had to wake to urinate at night, with 36% having to do so more than six times. Of the patients, 63% were able to distinguish between stool and urine. Initially, alkalinizing drugs to prevent metabolic acidosis were taken by 30% of the patients. Of previously medicated patients with a follow-up of >1 year, 8% required oral alkalinizing medication. CONCLUSION The Mainz Pouch II is a safe and reproducible urinary diversion, and serves as a satisfying alternative to other forms of continent urinary diversion inall age groups. The follow-up shows a low complication rate with good results in terms of continence. There were no significant differences in complication rates for the different ureteric implantation techniques. The long-term results remain to be evaluated.
机译:在本节中,有关于三种常见类型的尿流改道的论文。来自德国,希腊和土耳其的作者分别介绍了他们在Mainz袋II,S袋新膀胱和改良型Hautmann膀胱中的使用经验。目的探讨不同年龄段和使用不同输尿管植入技术的美因茨手袋II尿路改道的结果。患者与方法在1995年3月至2002年8月之间,共创建了Mainz Pouch II,用于41位患者(男27例,女14例,中位年龄56.3岁,范围2-75),肾单位81个(RU)。为了进行分析,将患者分为29岁(70%)<65岁和12岁(30%)> 65岁。 55 RU使用了采用Goodwin-Hohenfellner(GH)技术的输尿管植入术,其中23例使用了Abol-Enein(AE)修饰,三例使用了Le-Duc程序。随访中位数(范围)(可供36位患者使用,占88%)为19(1-80)个月。未经验证的问卷用于确定特定的尿液转移项目。结果7%的患者发生早期并发症,无一例需要手术干预。肾盂肾炎发生在36名患者中的5名和71 RU中的7名(14%的患者,10%的RU)中;所有患者均<65岁。 7例RU肾盂肾炎中有5例是由上尿路扩张引起的。无需手术修订。需要再植的输尿管狭窄发生在两个RU(2%,一个GH,一个AE)中。所有患者白天都是大陆。除一名患者外,所有患者都必须在晚上醒来小便,其中36%的患者必须这样做六次以上。在这些患者中,有63%能够区分粪便和尿液。最初,有30%的患者服用了碱化药物来预防代谢性酸中毒。在随访期超过1年的先前接受药物治疗的患者中,有8%需要口服碱化药物。结论Mainz Pouch II是一种安全且可重现的尿路改道,并且可以作为所有年龄段其他形式的大陆性尿路改道的令人满意的替代方案。随访显示并发症发生率低,节制效果良好。对于不同的输尿管植入技术,并发症发生率无显着差异。长期结果仍有待评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号